Probucol in Alzheimer's disease Study (PIA-Study)
Recent News
Read articles relating to the research and clinical trial below.
New Curtin research identifies likely cause of Alzheimer’s disease
Ground-breaking new Curtin University-led research has discovered a likely cause of Alzheimer’s disease, in a significant finding that offers potential new prevention and treatment opportunities for Australia’s second-leading cause of death.
Curtin Alzheimer's research project awarded NHMRC funding
New opportunities for the prevention and treatment of Alzheimer’s Disease will be further explored at Curtin-CHIRI, with our Director, Professor John Mamo, and his team receiving a $637K Ideas Grant from the National Health and Medical Research Council (NHMRC). Announced by Federal Health Minister Greg Hunt, the support will enable the team to further explore a remarkable discovery they have made in this area of research.
A research collaboration led by Curtin Health Innovation Research Institute (CHIRI) Director Professor John Mamo will get to trial a new treatment for the most common form of Alzheimer’s disease with the announcement of $1.72 million in Federal Government funding to Curtin University.
A $150,000 donation from MSWA will enable a research team at Curtin University led by CHIRI Director Professor John Mamo to embark on a pilot clinical trial of a drug that aims to prevent further memory loss in people living with Alzheimer’s disease.